ADVERSE DRUG REACTIONS

Cardiovascular events observed among patients in the etrasimod clinical programme: an integrated safety analysis of patients with moderately to severely active ulcerative colitis
Séverine Vermeire, David T Rubin, Laurent Peyrin-Biroulet, Marla C Dubinsky, Miguel Regueiro, Peter M Irving, Martina Goetsch, Krisztina Lazin, Guibao Gu, Joseph Wu, Irene Modesto, Aoibhinn McDonnell, Xiang Guo, Jesse Green, Alexis B Dalam, Andres J Yarur

BMJ Open Gastroenterology Jan 2025, 12 (1) e001516; DOI: 10.1136/bmjgast-2024-001516
Role of prescribed medication in the development of iron deficiency anaemia in adults—a case–control study
Kiran Prabhu, Frazer Warricker, Orouba Almilaji, Elizabeth Williams, Jonathon Snook

BMJ Open Gastroenterology Jun 2024, 11 (1) e001305; DOI: 10.1136/bmjgast-2023-001305
Increased rate of pancreatitis in gender diverse and transgender patients on hormone therapy: a case series study
Alexander Podboy, Catherine Casey, Ross C D Buerlein, Daniel S Strand, Vanessa M Shami, Andrew Y Wang

BMJ Open Gastroenterology Apr 2024, 11 (1) e001312; DOI: 10.1136/bmjgast-2023-001312
Risk of drug-related upper gastrointestinal bleeding in the total population of the Netherlands: a time-trend analysis
Ajda Bedene, Eveline L A van Dorp, Frits R Rosendaal, Albert Dahan, Willem M Lijfering

BMJ Open Gastroenterology Jan 2022, 9 (1) e000733; DOI: 10.1136/bmjgast-2021-000733
High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learning
Martin McDonnell, Richard J Harris, Florina Borca, Tilly Mills, Louise Downey, Suranga Dharmasiri, Mayank Patel, Benjamin Zare, Matt Stammers, Trevor R Smith, Richard Felwick, J R Fraser Cummings, Hang T T Phan, Markus Gwiggner

BMJ Open Gastroenterology Nov 2020, 7 (1) e000532; DOI: 10.1136/bmjgast-2020-000532
Bowel ulceration following tocilizumab administration in a COVID-19 patient
Damian Bruce-Hickman, Shanaz Matthew Sajeed, Yin Huei Pang, Choon Sheong Seow, Weihao Chen, Monika Gulati Kansal

BMJ Open Gastroenterology Aug 2020, 7 (1) e000484; DOI: 10.1136/bmjgast-2020-000484
Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia
Bin Wei, Fanpu Ji, Yee Hui Yeo, Eiichi Ogawa, Christopher D Stave, Shuangsuo Dang, Zongfang Li, Norihiro Furusyo, Ramsey C Cheung, Mindie H Nguyen

BMJ Open Gastroenterology Aug 2018, 5 (1) e000209; DOI: 10.1136/bmjgast-2018-000209
Safety of dual biological therapy in Crohn’s disease: a case series of vedolizumab in combination with other biologics
Eric J Mao, Sara Lewin, Jonathan P Terdiman, Kendall Beck

BMJ Open Gastroenterology Nov 2018, 5 (1) e000243; DOI: 10.1136/bmjgast-2018-000243
Real-world effectiveness of sofosbuvir plus ribavirin for chronic hepatitis C genotype 2 in Asia: a systematic review and meta-analysis
Bin Wei, Fanpu Ji, Yee Hui Yeo, Eiichi Ogawa, Biyao Zou, Christopher D Stave, Shuangsuo Dang, Zongfang Li, Norihiro Furusyo, Ramsey C Cheung, Mindie H Nguyen

BMJ Open Gastroenterology Jun 2018, 5 (1) e000207; DOI: 10.1136/bmjgast-2018-000207
Comparable efficacy with entecavir monotherapy and tenofovir–entecavir combination in chronic hepatitis B patients
Sumbella Baqai, James Proudfoot, Ronghui Xu, Steve Kane, Margaret Clark, Robert Gish

BMJ Open Gastroenterology Dec 2015, 2 (1) e000030; DOI: 10.1136/bmjgast-2015-000030

Main menu

ADVERSE DRUG REACTIONS

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

ADVERSE DRUG REACTIONS

Pages